Publication | Closed Access

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Tumor BiologyOncoprotein-induced AngiogenesisOncogenic AgentMedicineImmunologyCancer GrowthPathologyCancer Cell BiologyCancer BiologyRadiation OncologyLung CancerCancer ResearchViral OncologyCancer-associated Virus